SARAH BENNETT: Open Payments
NPI 1174305692 · DEBARY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,442 in 67 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,192 · 2025 $2,442
Food & beverage: $2,434Education: $8
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $648 |
| ABBVIE INC. | 14 | $415 |
| Regeneron Healthcare Solutions, Inc. | 8 | $286 |
| Novartis Pharmaceuticals Corporation | 6 | $258 |
| GENZYME CORPORATION | 8 | $198 |
| Organon LLC | 3 | $162 |
| UCB, Inc. | 4 | $96 |
| Arcutis Biotherapeutics, Inc. | 1 | $91 |
| Lilly USA, LLC | 3 | $79 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
Products named: OTEZLA, DUPIXENT, SKYRIZI, VTAMA, BOTOX, Bimzelx, Zoryve, Sotyktu.
Industry payments across FL — which companies pay providers there.
